Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Ovid Therapeutics Inc (NASDAQ: OVID) was $0.57 for the day, down -7.63% from the previous closing price of $0.62. In other words, the price has decreased by -$7.63 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
Our analysis of OVID’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.66 and its Current Ratio is at 5.66. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.
On April 30, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $9.
On April 29, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.H.C. Wainwright initiated its Buy rating on April 29, 2024, with a $9 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 27 ’25 when ALEXANDER MARGARET A. bought 6,810 shares for $0.73 per share. The transaction valued at 4,971 led to the insider holds 34,935 shares of the business.
LEVIN JEREMY M bought 18,248 shares of OVID for $50,364 on Mar 18 ’24. The CEO now owns 3,616,715 shares after completing the transaction at $2.76 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 64.29 while its Price-to-Book (P/B) ratio in mrq is 0.53.
Stock Price History:
Over the past 52 weeks, OVID has reached a high of $3.79, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is -29.55%, while the 200-Day Moving Average is calculated to be -55.67%.
Shares Statistics:
A total of 71.01M shares are outstanding, with a floating share count of 56.87M. Insiders hold about 19.92% of the company’s shares, while institutions hold 52.54% stake in the company.
